Company page

Transcode Therapeutics, Inc.

Transcode Therapeutics, Inc. (Ticker: RNAZ) is a public company based in the United States, focusing on innovative therapeutic solutions. With a market capitalization of approximately $6.28 million, the company is engaged in advancing its research and development efforts in the biotechnology sector. Transcode Therapeutics aims to address significant medical needs through its proprietary technologies.